CCRF-CEM-C7 Cells

The CCRF-CEM-C7 cell line is a clone derived from the parent CCRF-CEM cell line, which itself originates from a human acute lymphoblastic leukemia (ALL) of the T-cell type. This cell line was established from peripheral blood taken from a 4-year-old female patient with ALL. The CCRF-CEM-C7 cell line is extensively used in biomedical research, particularly in studies related to cancer biology, drug screening, and mechanisms of chemotherapy resistance.

CCRF-CEM-C7 cells are characterized by their robust growth in vitro and are commonly used to assess the cytotoxicity of anti-cancer compounds. These cells express several key markers of T-cell development and are often utilized to investigate T-cell leukemia pathogenesis, T-cell signaling pathways, and the cellular responses to DNA damage. The line has also been important in studies investigating the role of apoptosis in cancer cells, making it a valuable resource for understanding the mechanisms of programmed cell death in response to therapeutic agents.

Given its origin and characteristics, CCRF-CEM-C7 serves as a model system for T-cell acute lymphoblastic leukemia, providing insights into the biological behavior of this malignancy and offering a platform for testing therapeutic strategies targeting cellular pathways specific to T-cell malignancies.